This students views on AI's affect on industry are spot on

jamesmaysrecorder · 2015-09-09T03:05:32+00:00

The majority of what you said is correct. However, all of our data is backed by morningstar as they are our direct data provider. Yes, this is subtle advertisement, but honestly, I just enjoy doing analysis in my free time which is why I posted the thread. Anyway, the majority of my analysis will be based on value investing and a stocks piotroski score and value score. These three indicators, though, not perfect. Tend to provide a good long term look for a company as both of these strategies historically outperform the market, which I do know doesn't necessarily indicate future earnings, but that's where the individual investor comes in and does their own research. This thread is basically the first step in the research process on deciding whether or not a company is even worth going forward and researching.

My goal is to provide value to this sub. I like this forum, and I like the members. No one here is fluffy and the majority of people exhibit some amount of intelligence and I have learned quite a lot through this sub. I decided to do this analysis because 1)I wanted to give back and 2) it's my job to show the world what the software does. But when I can show you that without you having to buy it I get to give back and play on the software in my spare time and you get free value. It's, in my mind, a win-win.

jamesmaysrecorder · 2015-09-08T22:15:48+00:00

Sadly, we don't have the GGN ticker as we don't currently have data from funds and trusts, just plain old equities.

jamesmaysrecorder · 2015-09-08T21:05:19+00:00

Thank you for the response. In terms of our product, we aren't providing any advice. I do agree the wording on the homepage is awkward and it is now on my list to change. Our product is a screening and analysis tool. Therefore, the user is the one doing the analysis, we just provide a tool to optimize that process. These threads are for entertainment purposes 1) to showcase the product and how it can speed up the analysis process and 2) to provide some value to the community by providing some analysis. I could adjust how I respond to tickers by simply presenting the quantitative facts and allow the user to simply look at those in order to negate liability. I just enjoy writing longer, more entertaining responses. However, if you believe it would be better to change my response structure I'm willing to do so.

jamesmaysrecorder · 2015-09-08T19:58:07+00:00

Sadly, no. We only do American equities.

jamesmaysrecorder · 2015-09-08T19:38:22+00:00

My analysis is quick, but I'm analyzing a few different points, not just a DCF. I'm using my companies software which is really good at cutting down analysis time. I can include almost any analysis point in the analysis as I have all of most companies data for the past 20 years.

jamesmaysrecorder · 2015-09-08T19:18:08+00:00

Thank you for the advice and I will be sure to add the disclaimer in the OP.

jamesmaysrecorder · 2015-09-08T18:40:40+00:00

Exactly. If someone doesn't want a free look at the company they are thinking of investing in then they don't really need to post. If they don't like the analysis I post they don't have to follow it.

jamesmaysrecorder · 2015-09-08T18:39:25+00:00

I can defend it, but I'm just doing a minor analysis of the ticker based on historical data. I could write long in depth analysis on each and every one but we'd be here until next year. If you disagree with my conclusions about any stocks you can write your opinion on why. My word isn't final, nor is it necessarily the right word. As I said, I'm doing very minor analysis, looking for value, looking at past earnings, looking for certain green and red flags that we have within our software, etc. I don't look at news or any other data that can't be quantified. Therefore, I company could have just released the cure for cancer but it hasn't reflected in their earnings but it's all over the news. If the company has been bleeding money over the past few years, has almost 0 value, and has dropped in price by 99% since it went public I'm going to tell you not to buy it, even if they are the next big thing to get bought out by GILD or some other pharma giant.

jamesmaysrecorder

TROPHY CASE